| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6827551 | Schizophrenia Research | 2011 | 4 Pages |
Abstract
Results of this pilot trial do not support routine use of modafinil to counteract increased weight and metabolic diseases in patients taking clozapine. However, the effects of modafinil on weight and insulin regulation warrant further investigation with effect sizes of 0.4 to 0.6.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
David C. Henderson, Oliver Freudenreich, Christina P.C. Borba, Xingyue Wang, Paul M. Copeland, Eric Macklin, Xiaoduo Fan, Corinne Cather, Donald C. Goff,